Matthew Sorrentino to Follow-Up Studies
This is a "connection" page, showing publications Matthew Sorrentino has written about Follow-Up Studies.
Connection Strength
0.079
-
Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. J Am Heart Assoc. 2026 02 03; 15(3):e46943.
Score: 0.034
-
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
Score: 0.022
-
Follow-up to initial episode of atrial fibrillation. Postgrad Med. 1999 Oct 01; 106(4):35.
Score: 0.022